Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vatinoxan hydrochloride is an antagonist of the peripheral α2 adrenergic receptors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | Vatinoxan hydrochloride is an antagonist of the peripheral α2 adrenergic receptors. |
In vivo | When given simultaneously i.v Vatinoxan alone increases cardiac index and tissue oxygen delivery and has no deleterious adverse effects.In a dose-dependent manner Vatinoxan attenuates or prevents dexmedetomidine's systemic hemodynamic effects. A 50:1 dose ratio (Vatinoxan:dexmedetomidine) induces the least alterations in cardiovascular function[1]. Vatinoxan dose-dependently reduces bradycardia associated with dexmedetomidine and shortens the sedative effect without changing its quality. Vatinoxan may help reduce heart rate reduction in cats consciously administering dexmedetomidine[2]. |
Synonyms | MK-467 hydrochloride, L-659066 hydrochloride |
Molecular Weight | 454.97 |
Formula | C20H27ClN4O4S |
CAS No. | 130466-38-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 133 mg/mL (292.33 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vatinoxan hydrochloride 130466-38-5 GPCR/G Protein Neuroscience Adrenergic Receptor L 659066 Hydrochloride MK-467 hydrochloride MK 467 Hydrochloride L-659066 hydrochloride Vatinoxan Hydrochloride MK467 Hydrochloride MK-467 Hydrochloride L-659066 Hydrochloride L659066 Hydrochloride inhibitor inhibit